by dtrubin | Aug 14, 2019 | In the Press, monitoring, therapies
Dr. Mark Silverberg, Dr. David T Rubin, Dr. Laura Targownik, and Dr. Charabaty excitingly discuss why IBD specialists are divided on the topic of therapeutic drug monitoring (TDM). “If the drug is going to work but isn’t present in the body, it doesn’t do its job,”...
by dtrubin | Nov 27, 2018 | CD, In the Press, therapies
Dr. Rubin discusses how the management of Crohn disease has changed over time, the importance of understanding the disease for proper management, and common mistakes in treatment that remain.
by dtrubin | Sep 21, 2017 | In the Press, QoL, therapies
Surgery an Alternative to Infliximab for Some People With Crohn’s Disease By Marilynn Larkin Dr. David Rubin, Chief of the Section of Gastroenterology, Hepatology, and Nutrition at the University of Chicago Medicine, agreed: “For some patients, as difficult as it may...
